YOLFTbeta
Esthetics International Group

Esthetics International Group

5081 · KLSE · Consumer Defensive / Household & Personal Products

0.16MYR-0.02 (-11.11%)

Price History

Full chart

Market Stats

Previous Close0.18
Open0.18
Day Range0.16 – 0.18
52-Week Range0.175 – 0.30
Volume42.00K
Market Cap42.69M
P/E (TTM)0.00
Forward P/E0.00
EPS-0.01
Dividend Yield0.00%
Beta0.07
50-Day Avg0.1908
200-Day Avg0.1951

About

Esthetics International Group Berhad, an investment holding company, operates as a beauty and wellness company in Malaysia, Singapore, Hong Kong, and internationally. It operates through Professional Services and Sales, Product Distribution, E-Commerce, and Others segments. The company distributes skincare, haircare, and makeup products; hairstyling tools; aromatherapy products; and skin care equipment under the Davines, GHD, Jane Iredale, Tisserand, and Dermalogica brands. It also develops and distributes daily enzyme drink under the Bioxil Innertreats brand; and other skin care products under the Clinelle and Nurish Organiq brands. In addition, the company operates beauty and wellness centers; provides beauty and wellness services, as well as education and training in beauty and wellness, and management services; operates as an agent for trademarks and patents applications; develops and distributes fast moving consumer goods; retails beauty and wellness products through e-commerce; and invests in properties. Further, it owns and operates corporate outlets comprising AsterSpring skin care salons and clinic, retail stores, and department store counters. The company distributes its products through independent professional skincare, haircare salons, medispas, and clinics. The company was founded in 1984 and is headquartered in Shah Alam, Malaysia. Esthetics International Group Berhad operates as a subsidiary of Providence Capital Sdn Bhd.

Company Details

  • SectorConsumer Defensive
  • IndustryHousehold & Personal Products
  • CEOMr. Ngee Kai Chieng
  • Employees570
  • HeadquartersJalan Astaka U8/88, Shah Alam, Malaysia, 40150, Malaysia
  • Websitehttps://www.estheticsgroup.com

Leadership

  • Mr. Ing Huong Chieng BComm (UNSW), CA (Aust), CA (M'sia)Executive Chairman · b. 1957
  • Mr. Ngee Kai ChiengGroup MD, CEO & Executive Director · b. 1984
  • Mr. Ngee Wen ChiengExecutive Director · b. 1986
  • Ms. Wei Teng HooChief Financial Officer · b. 1978
  • Ms. Wai Ngan LeeCompany Secretary

Financials

Income Statement

Currency: MYR2012-03-312013-03-312014-03-312015-03-312016-03-312017-03-312018-03-312019-03-312020-03-312021-03-312022-03-312023-03-312024-03-312025-03-312026-03-31
Total Revenue132.00M134.00M143.00M151.00M158.34M160.94M159.28M168.16M170.60M129.48M124.59M165.10M179.32M183.63M194.96M
Growth (%)-+1.52%+6.72%+5.59%+4.86%+1.64%-1.03%+5.58%+1.45%-24.10%-3.78%+32.52%+8.61%+2.40%+6.17%
Cost of Revenue55.00M56.00M58.00M60.00M62.53M65.06M65.71M74.40M78.15M62.24M62.03M83.61M89.70M90.72M94.33M
Gross Profit78.00M78.00M85.00M91.00M95.81M95.87M93.57M93.76M92.45M67.24M62.56M81.49M89.63M92.91M100.63M
Gross Margin59.09%58.21%59.44%60.26%60.51%59.57%58.75%55.76%54.19%51.93%50.21%49.36%49.98%50.60%51.61%
Operating Expense73.00M69.00M66.00M71.00M75.84M77.74M90.64M82.35M85.40M65.56M69.76M84.12M88.85M99.04M100.11M
Operating Income5.00M9.00M19.00M20.00M19.98M18.14M2.93M11.41M7.05M1.68M-7.20M-2.63M779.00K-6.13M520.00K
Operating Margin3.79%6.72%13.29%13.25%12.62%11.27%1.84%6.79%4.13%1.30%-5.78%-1.59%0.43%-3.34%0.27%
EBITDA------12.44M20.20M36.59M29.05M17.40M21.44M26.38M20.31M26.27M
EBITDA Margin------7.81%12.01%21.45%22.43%13.96%12.99%14.71%11.06%13.48%
Net Income2.00M7.00M15.00M16.00M16.38M13.35M1.34M9.85M5.16M2.07M-6.13M-5.68M-1.55M-8.86M-3.32M
Net Income Margin1.52%5.22%10.49%10.60%10.34%8.29%0.84%5.86%3.03%1.60%-4.92%-3.44%-0.87%-4.82%-1.70%
Interest Expense0000000645.00K1.72M1.85M1.40M1.19M1.76M1.78M1.45M
Interest Expense % of Total Revenue0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.38%1.01%1.43%1.13%0.72%0.98%0.97%0.74%

Balance Sheet

Currency: MYR2012-03-312013-03-312014-03-312015-03-312016-03-312017-03-312018-03-312019-03-312020-03-312021-03-312022-03-312023-03-312024-03-312025-03-312026-03-31
Total Assets144.00M154.00M179.00M213.00M251.18M256.45M241.60M247.49M265.63M266.26M264.12M266.43M276.18M253.62M253.73M
Total Liabilities33.00M36.00M52.00M73.00M79.24M76.08M68.78M71.17M91.13M92.15M97.90M104.74M115.06M103.67M107.93M
Total Equity----171.93M180.37M172.82M176.32M174.50M174.11M166.22M161.69M161.12M149.95M145.80M
Cash49.00M63.00M60.00M64.00M-32.96M30.23M27.55M25.85M27.69M27.32M29.06M32.41M23.29M34.91M
Total Debt----18.03M18.95M17.13M16.82M24.85M27.61M-----

Cash Flow

Currency: MYR2008-03-312012-03-312013-03-312014-03-312015-03-312016-03-312017-03-312018-03-312019-03-312020-03-312021-03-312022-03-312023-03-312024-03-312025-03-312026-03-31
Operating Cash Flow-24.00M22.00M27.00M32.00M-2.93M24.98M6.99M9.92M23.47M21.89M13.44M12.67M16.59M17.21M32.36M
Investing Cash Flow--6.00M-9.00M-30.00M-33.00M-15.52M-10.37M-3.28M-3.60M5.06M194.00K5.81M10.51M9.96M-4.68M-
Financing Cash Flow-20.00M1.00M1.00M5.00M22.83M-6.87M-8.89M-8.87M-30.62M-20.13M-19.51M-21.73M-22.86M-23.33M-
Capital Expenditure06.00M9.00M30.00M25.00M24.37M4.85M2.95M2.73M2.69M3.40M1.18M2.17M4.62M4.85M3.10M
Free Cash Flow-------4.04M7.19M20.77M18.26M12.15M10.39M11.97M12.61M29.26M
Dividends Paid-----6.49M7.63M7.12M7.12M7.12M2.37M2.37M1.19M1.19M1.19M-
FCF to OCF-------57.76%72.49%88.51%83.43%90.40%82.05%72.14%73.27%90.41%
Dividend Paid to FCF-------176.23%98.97%34.25%12.99%19.53%11.41%9.91%9.41%-

Earnings

Report DateSep 2, 2009Dec 2, 2009Mar 3, 2010Jun 2, 2010Sep 1, 2010Dec 1, 2010Mar 2, 2011Jun 1, 2011Aug 31, 2011Nov 30, 2011May 30, 2012Aug 29, 2012Nov 28, 2012Feb 27, 2013May 29, 2013Aug 28, 2013Nov 27, 2013Feb 26, 2014May 28, 2014Sep 3, 2014Dec 3, 2014Feb 24, 2015Jun 3, 2015Sep 2, 2015Nov 18, 2015Feb 23, 2016May 24, 2016Aug 22, 2016Nov 16, 2016Feb 28, 2017May 31, 2017Aug 21, 2017Nov 28, 2017Feb 26, 2018May 25, 2018Aug 27, 2018Nov 21, 2018Feb 26, 2019May 28, 2019Aug 28, 2019Nov 20, 2019Mar 3, 2020May 22, 2020Aug 18, 2020Nov 26, 2020Feb 24, 2021Jun 1, 2021Sep 27, 2021Nov 25, 2021Feb 28, 2022May 30, 2022Aug 23, 2022Nov 24, 2022Feb 27, 2023May 31, 2023Aug 24, 2023Nov 29, 2023Feb 27, 2024May 30, 2024Aug 28, 2024Nov 27, 2024Feb 21, 2025May 29, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
EPS Estimate--------------------------------------------------------------------
EPS Actual0.010.020.01-0.04-0.02-0.14-0.08-0.06-0.020.010.010.010.000.020.010.020.020.020.010.020.020.010.020.020.020.020.020.010.010.020.010.000.000.00-0.000.010.010.010.010.010.000.01-0.00-0.010.010.000.01-0.03-0.020.010.01-0.01-0.00-0.01-0.000.000.000.00-0.01-0.00-0.020.01-0.020.00-0.01-0.00-0.010.00
Surprise--------------------------------------------------------------------
Timing------------------------------------------------------Pre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-market-----

Key Statistics & Ratios

Market Cap42.69M
Enterprise Value47.84M
Trailing P/E0.00
Forward P/E0.00
Price / Sales0.22
Price / Book0.29
EPS-0.01
Book Value0.621
Revenue (TTM)193.28M
Gross Profit (TTM)100.91M
EBITDA5.20M
Profit Margin-1.48%
Operating Margin3.73%
Return on Equity-1.92%
Return on Assets0.22%
Shares Outstanding237.19M
Shares Float13.43M
Beta0.07
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Dividends

20241×
0.01Oct 18, 2024
20231×
0.01Oct 19, 2023
20221×
0.01Oct 18, 2022
20212×
0.01Dec 16, 20210.01Oct 18, 2021
20202×
0.01Dec 17, 20200.01Oct 19, 2020
20192×
0.01Dec 12, 20190.02Sep 23, 2019
20182×
0.01Dec 12, 20180.02Sep 24, 2018
20172×
0.01Dec 13, 20170.02Sep 21, 2017
20162×
0.01Dec 13, 20160.02Sep 20, 2016
20152×
0.01Dec 11, 20150.02Sep 11, 2015
20142×
0.01Dec 11, 20140.01Sep 15, 2014
20132×
0.01Dec 3, 20130.03Sep 13, 2013
20102×
0.01Sep 15, 20100.01Apr 6, 2010
20091×
0.01Sep 16, 2009